Dr. Aniruddha (Anu) Hazra is an Associate Professor in the Section of Infectious Diseases and Global Health at the University of Chicago; he is Director of STI Services at the Chicago Center of HIV Elimination and director of the University's Infectious Diseases Fellowship Program. In addition to his work at UofC, he works at Howard Brown Health, the largest LGBTQ+ health provider in the country.
His clinical and research interests center on sexually transmitted infections and their impact on sexual and gender minorities as well as other vulnerable populations living on the South Side of Chicago. These interests are complemented by his clinical work in complex HIV management, PrEP care, hepatitis C management, gender affirming hormone therapy, high-resolution anoscopy, treatment of opioid use disorder, and medical education. As a former clinical ambassador of CDC's Let Stop HIV Together Campaign, he is passionate about equitable health care delivery to LGBTQ people of color.
Beth Israel Deaconess Medical Center
Boston, MA
- Infectious Diseases Fellowship
2018
Rush University Medical Center
Chicago, IL
- Chief Resident
2016
Rush University Medical Center
Chicago, IL
- Internal Medicine Residency
2015
Boston University School of Medicine
Boston, MA
MD - Medicine
2012
Boston University
Boston, MA
BA - Biochemistry & Molecular Biology; African Studies
2008
Brief Report: Detectable Coronary Artery Score Among People Living With HIV With Regional, Study, and Population Variations: A Systematic Review and Meta-Analysis.
Brief Report: Detectable Coronary Artery Score Among People Living With HIV With Regional, Study, and Population Variations: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):913-921.
PMID: 41860796
Efficacy and safety of oral type II topoisomerase inhibitors versus ceftriaxone-based regimens for the treatment of gonorrhoea: A systematic review and meta-analysis of randomised controlled trials.
Efficacy and safety of oral type II topoisomerase inhibitors versus ceftriaxone-based regimens for the treatment of gonorrhoea: A systematic review and meta-analysis of randomised controlled trials. J Infect Chemother. 2026 Sep; 32(9):103038.
PMID: 42486336
Virologic Outcomes With Lenacapavir in People With Human Immunodeficiency Virus: A Multicenter Real-World Study.
Virologic Outcomes With Lenacapavir in People With Human Immunodeficiency Virus: A Multicenter Real-World Study. Open Forum Infect Dis. 2026 Jul; 13(7):ofag425.
PMID: 42483034
Improving Anal Cancer Screening Messages Through Interviews From Men Who Have Sex With Men.
Improving Anal Cancer Screening Messages Through Interviews From Men Who Have Sex With Men. Health Educ Behav. 2026 Jun 15; 10901981261456322.
PMID: 42290537
Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.
Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis. Adv Ther. 2026 Aug; 43(8):3535-3551.
PMID: 42171901
The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study.
The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study. BMC Infect Dis. 2026 May 21; 26(1).
PMID: 42168904
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis. Clin Infect Dis. 2026 May 15.
PMID: 42140742
Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis at US Substance Use Treatment Facilities Treating Stimulant Use Disorder.
Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis at US Substance Use Treatment Facilities Treating Stimulant Use Disorder. J Acquir Immune Defic Syndr. 2026 May 01; 101(5):503-512.
PMID: 41570242
HIV diagnosis following psychiatric hospitalization among a large cohort of privately-insured people in the United States, 2003-2024.
HIV diagnosis following psychiatric hospitalization among a large cohort of privately-insured people in the United States, 2003-2024. Gen Hosp Psychiatry. 2026 May-Jun; 100:215-222.
PMID: 42019138
Anal Cancer Screening Prevalence in U.S. Cities and Factors Associated With Screening.
Anal Cancer Screening Prevalence in U.S. Cities and Factors Associated With Screening. Am J Prev Med. 2026 Sep; 71(3):108373.
PMID: 41966460